We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Synthes Confirms Potential $20B Acquisition By J&J

Law360 (April 18, 2011, 4:14 PM EDT) -- Synthes Inc. confirmed Monday that it is in talks with New Jersey-based medical device giant Johnson & Johnson about a merger that could value the Swiss-based medical device maker at $20 billion.

A purchase of Synthes, with its 2010 net sales of more than $3.6 billion, likely is seen by J&J as a method of quickly boosting earnings after a year in which the pharmaceutical giant saw drops in sales and earnings growth.

Over the last 10 years Synthes has increased its revenues from $900 million...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.